Brevera® Breast Biopsy System

Brevera Biopsy System Needle

    Overview

    Documents

    Training

    Clarity at the Point of Care

    The world’s first and only breast biopsy solution that combines tissue acquisition, real-time imaging, and advanced specimen separation. Brevera biopsy system streamlines the entire breast biopsy process from start to finish and ensures you have the information you need at point of care.

    There’s no pausing the procedure. No moving to an imaging system. No waiting for sample verification. No interrupting your screening schedule. No wondering about whether or not you retrieved what you needed. With Brevera system you get the information you need in as little as 8 seconds per core.1

    Brevera system will change the way you think about performing breast biopsies.

    Give Your Patients a More Compassionate Biopsy Experience

    Patient-centric Care

    9 out of every 10 patients surveyed felt less uncomfortable with their Brevera Breast Biopsy procedure than they expected.2

    Minimally Invasive

    Brevera stereotactic breast biopsy system is designed to provide patients a positive experience with maximized core retrieval and minimal incision size.3

    Faster than Expected

    Ease fears and alleviate discomfort. Over 92% of patients surveyed reported that the biopsy experience was faster than expected.2

    Workflow and Facility Improvements

    Simplified Inventory Management Body

    A dual-function disposable needle, offering both standard and petite sizes in one, while cutting down waste by 54%.4

    Fewer Steps

    The Brevera system’s 8-second acquisition and imaging cycle gives more actionable information at the point of care so physicians can make decisions with confidence.1

    Patient Satisfaction

    Fast, accurate and streamlined procedures mean patients spend less time under compression. Integrated pain-management administration and quiet remote firing can result in a more positive biopsy experience for providers and patients.5

    Optimized Technologist Workflow

    Little to no manual handling post-biopsy helps maintain sample integrity from patient to pathology, improving technologists' workflow.

    Improved Sample Identification

    Samples are automatically sorted and directed into a 12-chamber tissue filter, each chamber labeled to correspond with the specimen radiographs for accurate correlation whether in radiology or pathology.

    Brevera_3D_Image

    Click and drag below to rotate the device for a 360° view.

    Transforming Breast Biopsy in Real-Time

    Brevera Breast Biopsy system is the first and only breast biopsy system to unite vacuum assisted tissue acquisition with real-time imaging, specimen verification, and post-biopsy handling in a single system. Learn how this winning combination enhances the patient experience and transforms the breast biopsy procedure.

    Videos

    "It was standard for us to take 12 samples during a biopsy; now we take three or four samples because I can  clearly see that I am getting what I need. This improves the patient’s experience because it reduces time spent under compression in addition to reducing the potential for bleeding and other complications."

    Dr. Madelyn Lefranc Director of Breast Imaging Services at Franciscan Health

    "This technology is a game changer for patient and for the workflow of the center... “With Brevera system, you have the technology in the room to make the procedure go as quickly and safely as possible"

    Harriet Borofsky, MD Hackensack Meridian Health, NJ

    "The tissue collection for the Brevera system has been a great improvement as compared to our prior tissue collection methods."

    Dr. Madelyn Lefranc Director of Breast Imaging Services at Franciscan Health

    "Brevera system helps us increase capacity to offer more biopsies in a day. I consider it the next generation of biopsy devices.”

    Harriet Borofsky, MD Hackensack Meridian Health, NJ

    Product Gallery

      Important Safety Information:
      The Brevera breast biopsy system with CorLumina® imaging technology is not intended for therapeutic applications. The Brevera breast biopsy system with CorLumina imaging technology is contraindicated for those patients who, based on the physician’s judgment, may be at increased risk or develop complications associated with core removal or biopsy. Patients receiving anticoagulant therapy or who may have bleeding disorders may be considered at increased risk of procedural complications. For detailed benefit and risk information, please consult the IFU.
      1. Hologic Data on File 2022. Brevera Reusable Driver Functionality Verification Report (VER-11549-001) 2. A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera® Breast Biopsy System. 3. Hologic Data on file, Compared with Mammotome Revolve™ 8G 4. Compared to Eviva® device. Hologic Data on file. 5. 2015 Kadence International survey of 200 healthcare professionals.
      FDA clearance K163052 
      Views and opinions expressed herein by third parties are theirs alone and do not necessarily reflect those of Hologic. The Health Care Professionals are paid Hologic consultants